HK Stock Market Move | GCL TECH (03800) rose over 5% in late trading. GCL's 400,000-ton lithium iron phosphate project breaks ground, transforming into a global multi-product new energy materials platform.
GCL TECH (03800) rose over 5% in late trading. As of press time, it was up 4.93% at HK$0.745, with a turnover of HK$115 million.
GCL TECH (03800) rose over 5% in late trading. As of press time, it was up 4.93% at HK$0.745, with a turnover of HK$115 million.
On the news front, on September 28, XuZhou XinRui Lithium Battery's 400,000-ton lithium iron phosphate project officially broke ground in the Xuzhou Economic and Technological Development Zone. This came just 24 days after the energy conservation report received administrative approval on September 4. The project involves a total investment of RMB 4 billion and, once completed, will have an annual production capacity of 400,000 tons of lithium battery cathode materials. The project breaking ground is another major layout by GCL Group to cultivate a new engine in the new energy sector.
Public information shows that in May this year, GCL TECH released its "Overall Strategic Transformation Plan," announcing that the company would transform from a "single-product champion in granular silicon" to a "global multi-product new energy materials platform," expanding from a single granular silicon business to an industrial ecosystem of "silicon-based + lithium-based + carbon-based" materials, and further extending into cutting-edge new energy materials. Among these, lithium iron phosphate will serve as GCL TECH's core growth engine.
Related Articles

A-share Closing Review | Shanghai Composite Index rises 0.31%, pharmaceuticals and biologics lead gains, STAR 50 falls 2.51%

HK Stock Market Move | HENLIUS(02696) rises nearly 6% as the value of the company's core pipeline continues to be validated; H drug to disclose U.S. patient data for the first time.

Eli Lilly (LLY.US) triple agonist announces Phase III data
A-share Closing Review | Shanghai Composite Index rises 0.31%, pharmaceuticals and biologics lead gains, STAR 50 falls 2.51%

HK Stock Market Move | HENLIUS(02696) rises nearly 6% as the value of the company's core pipeline continues to be validated; H drug to disclose U.S. patient data for the first time.

Eli Lilly (LLY.US) triple agonist announces Phase III data






